Angiotensin II modulates CD40 expression in vascular smooth muscle cells

Clinical Science

Volumn 116, Issue 5, 2009, Pages 423-431

  Souza, Heraldo P ^a   Frediani, Denise ^a   Cobra, Ana L ^a   Moretti, Ana I ^a   Jurado, Márcia C ^a   Fernandes, Thadeu R ^a   Cardounel, Arturo J ^b   Zweier, Jay L ^b   Tostes, Rita C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; CD40; Cytokine; Electron paramagnetic resonance; Hypertension; Superoxide

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN II; ANTISENSE OLIGONUCLEOTIDE; CD40 ANTIGEN; CD40 LIGAND; CYCLOOXYGENASE 2; DIPHENYLIODONIUM SALT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; PROTEIN P22; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE PRODUCTION; ELECTRON SPIN RESONANCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INCUBATION TIME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANTIGENS, CD40; ANTIOXIDANTS; CD40 LIGAND; CELLS, CULTURED; CORONARY VESSELS; CYTOKINES; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 63449130747     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080155     Document Type: Article

References (43)

1. Mehta, P. K. and Griendling, K. K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 292, C82-C97
2. Dandona, P., Dhindsa, S., Ghanim, H. and Chaudhuri, A. (2007) Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J. Hum. Hypertens. 21, 20-27
3. Muller, D. N., Mervaala, E. M., Schmidt, F. et al. (2000) Effect of bosentan on NF-κB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension 36, 282-290
4. Hernandez-Presa, M. A., Bustos, C., Ortego, M., Tunon, J., Ortega, L. and Egido, J. (1998) ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. Am. J. Pathol. 153, 1825-1837
5. Hernandez-Presa, M., Bustos, C., Ortego, M. et al. (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95, 1532-1541
6. Schmieder, R. E., Hilgers, K. F., Schlaich, M. P. and Schmidt, B. M. (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369, 1208-1219
7. Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D. et al. (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 101, 1372-1378
8. Ruiz-Ortega, M., Ruperez, M., Lorenzo, O. et al. (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney. Int. Suppl. S12-S22
9. Schiffrin, E. L., Park, J. B., Intengan, H. D. and Touyz, R. M. (2000) Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101, 1653-1659
10. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. and Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 145-153
11. Touyz, R. M. (2004) Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Braz. J. Med. Biol. Res. 37, 1263-1273
12. Souza, H. P., Laurindo, F. R., Ziegelstein, R. C., Berlowitz, C. O. and Zweier, J. L. (2001) Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am. J. Physiol. Heart. Circ. Physiol. 280, H658-H667
13. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
14. Libby, P. (2000) Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am. J. Cardiol. 86, 3J-8J
15. Lutgens, E., Lievens, D., Beckers, L., Donners, M. and Daemen, M. (2007) CD40 and its ligand in atherosclerosis. Trends Cardiovasc. Med. 17, 118-123
16. Schonbeck, U. and Libby, P. (2001) CD40 signaling and plaque instability. Circ. Res. 89, 1092-1103
17. Schonbeck, U., Mach, F., Sukhova, G. K. et al. (1999) Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J. Exp. Med. 189, 843-853
18. Schonbeck, U., Mach, F., Sukhova, G. K. et al. (2000) CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol. 156, 7-14
19. Heeschen, C., Dimmeler, S., Hamm, C. W. et al. (2003) Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 348, 1104-1111
20. Aukrust, P., Muller, F., Ueland, T. et al. (1999) Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100, 614-620
21. Varo, N., de Lemos, J. A., Libby, P. et al. (2003) Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 108, 1049-1052
22. Gilliam, A. C., Kremer, I. B., Yoshida, Y. et al. (1998) The human hair follicle: a reservoir of CD40 + B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J. Invest. Dermatol. 110, 422-427
23. McLellan, A. D., Sorg, R. V., Williams, L. A. and Hart, D. N. (1996) Human dendritic cells activate T lymphocytes via a CD40:CD40 ligand-dependent pathway. Eur. J. Immunol. 26, 1204-1210
24. Law, C. L.,Wormann, B. and LeBien, T.W. (1990) Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia 4, 732-738
25. Mach, F., Schonbeck, U., Sukhova, G. K. et al. (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 94, 1931-1936
26. phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 14, 1518-1528
27. Souza, H. P., Liu, X., Samouilov, A., Kuppusamy, P., Laurindo, F. R. and Zweier, J. L. (2002) Quantitation of superoxide generation and substrate utilization by vascular NAD(P)H oxidase. Am. J. Physiol. Heart. Circ. Physiol. 282, H466-H474
28. Pinchuk, L. M., Klaus, S. J., Magaletti, D. M., Pinchuk, G. V., Norsen, J. P. and Clark, E. A. (1996) Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J. Immunol. 157, 4363-4370
29. phox in human coronary arteries. Circulation 100, 1494-1498
30. Lassegue, B. and Clempus, R. E. (2003) Vascular NAD(P)H oxidases: specific features, expression and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R277-R297
31. Krzesz, R., Wagner, A. H., Cattaruzza, M. and Hecker, M. (1999) Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB and signal transducer and activation of transcription-1. FEBS Lett. 453, 191-196
32. Nguyen, V. T. and Benveniste, E. N. (2002) Critical role of tumor necrosis factor-α and NF-κB in interferon-γ-induced CD40 expression in microglia/macrophages. J. Biol. Chem. 277, 13796-13803
33. Wolin, M. S., Burke-Wolin, T. M. and Mohazzab, H. K. (1999) Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms. Respir. Physiol. 115, 229-238
34. Azevedo, L. C., Pedro, M. A., Souza, L. C. et al. (2000) Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 47, 436-445
35. Souza, H. P., Souza, L. C., Anastacio, V. M. et al. (2000) Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radical Biol. Med. 28, 1232-1242
36. Nguyen, V. T. and Benveniste, E. N. (2000) Involvement of STAT-1 and ets family members in interferon-γ induction of CD40 transcription in microglia/macrophages. J. Biol. Chem. 275, 23674-23684
37. Schonbeck, U. and Libby, P. (2001) The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58, 4-43
38. 2+/calmodulin kinase type IV/Gr and calcineurin. J. Immunol. 162, 2057-2063
39. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M. G. and Packer, L. (1997) Redox regulation of NF-κB activation. Free Radical Biol. Med. 22, 1115-1126
40. Flescher, E., Tripoli, H., Salnikow, K. and Burns, F. J. (1998) Oxidative stress suppresses transcription factor activities in stimulated lymphocytes. Clin. Exp. Immunol. 112, 242-247
41. Ruef, J., Browatzki, M., Pfeiffer, C. A., Schmidt, J. and Kranzhofer, R. (2007) Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2. Vasc. Med. 12, 23-27
42. Tziakas, D. N., Chalikias, G. K., Kaski, J. C. et al. (2007) Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis 193, 196-203
43. Cipollone, F., Rocca, B. and Patrono, C. (2004) Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arterioscler. Thromb. Vasc. Biol. 24, 246-255